-
Mashup Score: 5
LARVOL – The Annual Clinical Trials in Oncology East Coast 2024 / Annual Clinical Trials in Oncology, cancer, LARVOL, OncoDaily, Oncology
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
LARVOL At The Annual Clinical Trials in Oncology East Coast 2024 / Annual Clinical Trials in Oncology East Coast 2024, boston, Bruno Larvol, cancer, clinical
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: LARVOL At The Annual Clinical Trials in Oncology East Coast 2024 @Larvol @brunolarvol https://t.co/WniniorpGw #MedicalCo…
-
-
Mashup Score: 1Why cancer risk declines sharply in old age - 6 month(s) ago
Nature – New research identifies some of the genes that could help to explain why lung cancer incidence rises with age but declines after the age of 75.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
RT @mac_jamil: https://t.co/dXpV2IQgOe
-
-
Mashup Score: 2Amol Akhade: P53 for endometrial cancer - OncoDaily - 7 month(s) ago
Amol Akhade: P53 for endometrial cancer / Amol Akhade, cancer, Endometrial cancer, OncoDaily, Oncology, p53 Mutation, PARP inhibitors
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: P53 for endometrial cancer - @SuyogCancer @myESMO https://t.co/8gfhn24uG5 #Cancer #ESMO #EndometrialCancer #OncoDaily #Onco…
-
-
Mashup Score: 3Results of ECHO study EHA - OncoDaily - 7 month(s) ago
Results of ECHO study EHA / Acala-BR, cancer, double blind, EHA2024, Graham Collins, OncoDaily, Oncology, placebo-controlled, randomised, Wang – Echo study
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Results of ECHO study @EHA_Hematology @graham74GC https://t.co/Z9w8yxw9Kg #Cancer #EHA2024 #LYMsm #OncoDaily #Oncology http…
-
-
Mashup Score: 1LinkedIn - 7 month(s) ago
This link will take you to a page that’s not on LinkedIn
Source: lnkd.inCategories: General Medicine News, Hem/OncsTweet-
RT @Onco_Cifu88: Limited SCLC: I will treat with a year of adjuvant DURVA after CT-RT. 🫁 ADRIATIC 👉🏼 https://t.co/a1k9lEvepk
-
-
Mashup Score: 20ASCO 2024 - American Society of Clinical Oncology Annual Meeting - 8 month(s) ago
Check this out – Top Trials for ASCO 2024 – American Society of Clinical Oncology Annual Meeting
Source: clin.larvol.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/zNsg4yBRuP. @mtmdphd @SuyogCancer @kevinpunie top #asco24 trials with top buzz. Any surprises so far? https://t.co/AvLIEFITtG
-
-
Mashup Score: 4Tune in to the LARVOL ONCOLOGY DATA WEBINAR - OncoDaily - 8 month(s) ago
Tune in to the LARVOL ONCOLOGY DATA WEBINAR / ASCO 2024, ASCO24, cancer, LARVOL, LARVOL ONCOLOGY DATA WEBINAR, OncoDaily, Oncology
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Tune in to the @Larvol ONCOLOGY DATA WEBINAR @ASCO https://t.co/cbJkPU5hnt #ASCO24 #Cancer #LARVOL #ONCOLOGYDATA #WEBINAR…
-
-
Mashup Score: 1Webprogram Unavailable - 9 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
RT @ManniMD1: 3) DSM XIII Mel 140 could not beat continuous len/dex in an older patient population. https://t.co/9NykX9rJkd
-
-
Mashup Score: 6
Kenneth C. Anderson, MD, discusses the recent FDA ODAC decision regarding the use of cilta-cel in relapsed/refractory multiple myeloma.
Source: www.onclive.comCategories: General Medicine News, Hem/OncsTweet-
RT @IMFjimMYELOMA: Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma https://t.co/m60m3JpoMs via @onclive Ev…
-
RT @oncodaily: The Annual Clinical Trials in Oncology East Coast 2024 - @Larvol @brunolarvol https://t.co/bDYVCEiIYY #AnnualClinicalTria…